AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 3279769 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 27
Study 29497963 — intervention group
Group type: EXPERIMENTAL
Intervention: High Intensity (HI) exercise
Number of subjects: 277
Study 29497963 — intervention group
Group type: COMPARATOR
Intervention: Low-to-moderate Intensity (LMI) exercise
Number of subjects: 277
Study 24997863 — intervention group
Group type: EXPERIMENTAL
Intervention: Rg3-enriched Korean red ginseng (400 mg)
Number of subjects: 23
Study 24997863 — intervention group
Group type: COMPARATOR
Intervention: Wheat bran (400 mg)
Number of subjects: 23
Study 22081263 — intervention group
Group type: EXPERIMENTAL
Intervention: Darbepoetin alfa (DA) 500 mcg every 3 weeks (Q3 W) or 2.25 mcg/kg DA weekly (QW) for 15 weeks
Number of subjects: 705
Study 22081263 — intervention group
Group type: EXPERIMENTAL
Intervention: Darbepoetin alfa (DA)
Number of subjects: 705
Study 19929694 — intervention group
Group type: EXPERIMENTAL
Intervention: DNA/DNA regimen
Number of subjects: 307
Study 19929694 — intervention group
Group type: EXPERIMENTAL
Intervention: DNA/Ad5 regimen
Number of subjects: 307
Study 19929694 — intervention group
Group type: EXPERIMENTAL
Intervention: Ad5/Ad5 regimen
Number of subjects: 307
Study 19929694 — intervention group
Group type: COMPARATOR
Intervention: Ad5 vaccine alone
Number of subjects: 307
Study 19025505 — intervention group
Group type: EXPERIMENTAL
Intervention: Physiotherapist-directed program of advice and exercises
Number of subjects: 56
Study 19025505 — intervention group
Group type: COMPARATOR
Intervention: Control group (no physiotherapy intervention)
Number of subjects: 56
Study 16188181 — intervention group
Group type: EXPERIMENTAL
Intervention: KTP 532 nm laser treatment
Number of subjects: 26
Study 16188181 — intervention group
Group type: COMPARATOR
Intervention: Control side (no treatment)
Number of subjects: 26
Study 12535050 — intervention group
Group type: EXPERIMENTAL
Intervention: Dissolvable collagen punctal plugs (lower puncta occluded)
Number of subjects: 62
Study 12535050 — intervention group
Group type: EXPERIMENTAL
Intervention: Dissolvable collagen punctal plugs (both upper and lower puncta occluded)
Number of subjects: 62
Study 12535050 — intervention group
Group type: COMPARATOR
Intervention: Age- and gender-matched normals (control group)
Number of subjects: 62
Study 12359987 — intervention group
Group type: EXPERIMENTAL
Intervention: Nitrendipine
Number of subjects: 1026
Study 12359987 — intervention group
Group type: EXPERIMENTAL
Intervention: Atenolol
Number of subjects: 1026
Study 12359987 — intervention group
Group type: EXPERIMENTAL
Intervention: Captopril
Number of subjects: 1026
Study 12359987 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined medication (Nitrendipine, Atenolol, Captopril)
Number of subjects: 1026
Study 8617693 — intervention group
Group type: EXPERIMENTAL
Intervention: Light box (N=9)
Number of subjects: 43
Study 8617693 — intervention group
Group type: EXPERIMENTAL
Intervention: Head-mounted unit (HMU) (N=12)
Number of subjects: 43
Study 8617693 — intervention group
Group type: COMPARATOR
Intervention: Placebo light box (N=12)
Number of subjects: 43
Study 8617693 — intervention group
Group type: COMPARATOR
Intervention: Placebo HMU (N=10)
Number of subjects: 43
Study 2024567 — intervention group
Group type: EXPERIMENTAL
Intervention: mepivacaine 2% + adrenaline 1:200,000 (n = 20)
Number of subjects: 40
Study 2024567 — intervention group
Group type: COMPARATOR
Intervention: mepivacaine 2% (n = 20)
Number of subjects: 40
Study 7259925 — intervention group
Group type: EXPERIMENTAL
Intervention: Cimetidine 800 mg/day
Number of subjects: 19
Study 7259925 — intervention group
Group type: EXPERIMENTAL
Intervention: Cimetidine 1600 mg/day
Number of subjects: 19
Study 7259925 — intervention group
Group type: EXPERIMENTAL
Intervention: Cimetidine withdrawal
Number of subjects: 19
Study 7259925 — intervention group
Group type: EXPERIMENTAL
Intervention: Cimetidine pharmacokinetics
Number of subjects: 19
Study 31297681 — intervention group
Group type: EXPERIMENTAL
Intervention: Incentive participants earned up to $10 per day for 2 years for providing blood samples that showed either reduced or undetectable viral loads.
Number of subjects: 102
Study 31297681 — intervention group
Group type: COMPARATOR
Intervention: Usual Care
Number of subjects: 102
Study 28729305 — intervention group
Group type: EXPERIMENTAL
Intervention: Cunningham biomechanical reposition technique
Number of subjects: 0
Study 28729305 — intervention group
Group type: EXPERIMENTAL
Intervention: Modified Milch biomechanical reposition technique
Number of subjects: 0
Study 28729305 — intervention group
Group type: EXPERIMENTAL
Intervention: Scapular manipulation biomechanical reposition technique
Number of subjects: 0
Study 26500019 — intervention group
Group type: EXPERIMENTAL
Intervention: web-based CBT (3 F2F sessions and up to 8 web-based modules over 6 months)
Number of subjects: 132
Study 26500019 — intervention group
Group type: COMPARATOR
Intervention: care as usual (waiting list for regular F2F CBT for 6 months)
Number of subjects: 132
Study 26500019 — intervention group
Group type: EXPERIMENTAL
Intervention: web-based CBT
Number of subjects: 132
Study 22999319 — intervention group
Group type: EXPERIMENTAL
Intervention: Functional‐rTMS (EMG‐triggered rTMS)
Number of subjects: 18
Study 22999319 — intervention group
Group type: COMPARATOR
Intervention: Passive‐rTMS (rTMS only; control)
Number of subjects: 18
Study 21239090 — intervention group
Group type: EXPERIMENTAL
Intervention: High Protein (HP) diet (3.0 g protein/kg BW) for 3 weeks
Number of subjects: 23
Study 21239090 — intervention group
Group type: COMPARATOR
Intervention: Usual Protein (UP) diet (1.5 g protein/kg BW) for 3 weeks
Number of subjects: 23
Study 19994682 — intervention group
Group type: EXPERIMENTAL
Intervention: Gaining in wisdom and activating channels group
Number of subjects: 60
Study 19994682 — intervention group
Group type: EXPERIMENTAL
Intervention: JIN's 3‐needling group
Number of subjects: 60
Study 19994682 — intervention group
Group type: COMPARATOR
Intervention: Routine acupuncture group
Number of subjects: 60
Study 17823422 — intervention group
Group type: EXPERIMENTAL
Intervention: High vitamin E diet
Number of subjects: 251
Study 15330150 — intervention group
Group type: EXPERIMENTAL
Intervention: steroids and oral magnesium
Number of subjects: 28
Study 15330150 — intervention group
Group type: COMPARATOR
Intervention: steroids and placebo
Number of subjects: 28
Study 11548916 — intervention group
Group type: EXPERIMENTAL
Intervention: Strength-trained group (80% 1RM - average training velocity = .308 m/s)
Number of subjects: 21
Study 11548916 — intervention group
Group type: EXPERIMENTAL
Intervention: Power-trained group (60% 1RM - average training velocity = .398 m/s)
Number of subjects: 21
Study 11548916 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 21
Study 9628402 — intervention group
Group type: EXPERIMENTAL
Intervention: Rapid aiming movements with peripheral and/or central feedback information
Number of subjects: 0
Study 9628402 — intervention group
Group type: COMPARATOR
Intervention: Control of aiming movements with feedback information
Number of subjects: 0
Study 7740465 — intervention group
Group type: EXPERIMENTAL
Intervention: 30 micrograms ethinyloestradiol combination
Number of subjects: 2
Study 7740465 — intervention group
Group type: COMPARATOR
Intervention: 20 micrograms ethinyloestradiol combination
Number of subjects: 2
Study 7740465 — intervention group
Group type: COMPARATOR
Intervention: Comparison between 30 micrograms and 20 micrograms ethinyloestradiol combinations
Number of subjects: 2
Study 2965633 — intervention group
Group type: EXPERIMENTAL
Intervention: Atrial natriuretic peptide (ANP)
Number of subjects: 8
Study 2965633 — intervention group
Group type: EXPERIMENTAL
Intervention: Angiotensin II (ANG II)
Number of subjects: 8
Study 2965633 — intervention group
Group type: EXPERIMENTAL
Intervention: ANP with background infusion of ANG II
Number of subjects: 8
Study 31859677 — intervention group
Group type: EXPERIMENTAL
Intervention: Mobile phone‐based physical activity education (mPED) intervention
Number of subjects: 203
Study 31859677 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 203
Study 29178700 — intervention group
Group type: EXPERIMENTAL
Intervention: Group A: Manual curettes, sonic-driven scaler, and prophylaxis brush
Number of subjects: 105
Study 29178700 — intervention group
Group type: EXPERIMENTAL
Intervention: Group B: Manual curettes, air polishing with glycine powder, and prophylaxis brush
Number of subjects: 105
Study 29178700 — intervention group
Group type: COMPARATOR
Intervention: Group C: Manual curettes, sonic-driven scaler, and prophylaxis brush with chlorhexidine varnish
Number of subjects: 105
Study 29178700 — intervention group
Group type: EXPERIMENTAL
Intervention: Group D: Manual curettes, air polishing with glycine powder, and prophylaxis brush with chlorhexidine varnish
Number of subjects: 105
Study 24131567 — intervention group
Group type: EXPERIMENTAL
Intervention: Virtual Reality Exposure Therapy (VRE)
Number of subjects: 63
Study 24131567 — intervention group
Group type: COMPARATOR
Intervention: Exposure Group Therapy (EGT)
Number of subjects: 63
Study 23235922 — intervention group
Group type: EXPERIMENTAL
Intervention: Fasting for 60 hours
Number of subjects: 10
Study 21729424 — intervention group
Group type: EXPERIMENTAL
Intervention: Group B (symptom) - read vignettes describing symptoms of dementia
Number of subjects: 494
Study 21729424 — intervention group
Group type: EXPERIMENTAL
Intervention: Group C (label) - read vignettes with a diagnostic label of dementia
Number of subjects: 494
Study 21729424 — intervention group
Group type: COMPARATOR
Intervention: Group A (control) - responded to stigma questions directly
Number of subjects: 494
Study 17625032 — intervention group
Group type: EXPERIMENTAL
Intervention: 5 mW laser irradiation (650 nm), applied transmeatally for 15 minutes, once daily for a week
Number of subjects: 45
Study 17625032 — intervention group
Group type: COMPARATOR
Intervention: Placebo laser
Number of subjects: 45
Study 17069104 — intervention group
Group type: EXPERIMENTAL
Intervention: Respiratory specialists (RS)
Number of subjects: 472
Study 17069104 — intervention group
Group type: COMPARATOR
Intervention: Primary care physicians
Number of subjects: 472
Study 14508737 — intervention group
Group type: EXPERIMENTAL
Intervention: Molloplast‐B
Number of subjects: 20
Study 14508737 — intervention group
Group type: COMPARATOR
Intervention: MPDS‐SL
Number of subjects: 20
Study 10627439 — intervention group
Group type: EXPERIMENTAL
Intervention: Syndecan-1 elevated in patients (median, 643 units/mL)
Number of subjects: 174
Study 10627439 — intervention group
Group type: EXPERIMENTAL
Intervention: Syndecan-1 as a continuous variable in multivariate Cox regression model
Number of subjects: 174
Study 10627439 — intervention group
Group type: EXPERIMENTAL
Intervention: Syndecan-1 dichotomized by best cutoff (66th percentile, 1170 units/mL)
Number of subjects: 174
Study 9358622 — intervention group
Group type: EXPERIMENTAL
Intervention: ELISA-PCR method for HPA-1 genotyping
Number of subjects: 100
Study 1302384 — intervention group
Group type: EXPERIMENTAL
Intervention: Passive drain
Number of subjects: 150
Study 1302384 — intervention group
Group type: EXPERIMENTAL
Intervention: Closed suction drain
Number of subjects: 150
Study 1302384 — intervention group
Group type: COMPARATOR
Intervention: No drain
Number of subjects: 150
Study 2931937 — intervention group
Group type: EXPERIMENTAL
Intervention: Endoscopic injection sclerotherapy (ST)
Number of subjects: 107
Study 2931937 — intervention group
Group type: COMPARATOR
Intervention: Conservative therapy (balloon tamponade and/or vasopression infusion)
Number of subjects: 107
Study 29678977 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexmedetomidine (sleep-inducing dose)
Number of subjects: 370
Study 29678977 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 370
Study 26915831 — intervention group
Group type: EXPERIMENTAL
Intervention: Benzoyl peroxide 3% and clindamycin 1% (BPO + CLN)
Number of subjects: 215
Study 26915831 — intervention group
Group type: COMPARATOR
Intervention: Azelaic acid 20% (AzA)
Number of subjects: 215
Study 24574278 — intervention group
Group type: EXPERIMENTAL
Intervention: Xylometazoline
Number of subjects: 42
Study 24574278 — intervention group
Group type: EXPERIMENTAL
Intervention: Xylitol (Xlear Nasal Spray®)
Number of subjects: 42
Study 24574278 — intervention group
Group type: COMPARATOR
Intervention: Physiological saline
Number of subjects: 42
Study 22190336 — intervention group
Group type: EXPERIMENTAL
Intervention: Extended theory of planned behavior (TPB) intervention for 4 weeks
Number of subjects: 183
Study 22190336 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 183
Study 20008025 — intervention group
Group type: EXPERIMENTAL
Intervention: Tobacco use intervention (specific details not provided)
Number of subjects: 11642
Study 17396687 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard PRP (19 eyes)
Number of subjects: 57
Study 17396687 — intervention group
Group type: EXPERIMENTAL
Intervention: Selective PRP (20 eyes)
Number of subjects: 57
Study 17396687 — intervention group
Group type: EXPERIMENTAL
Intervention: PDT (17 eyes)
Number of subjects: 57
Study 17396687 — intervention group
Group type: COMPARATOR
Intervention: All groups (PRP, selective PRP, PDT)
Number of subjects: 57
Study 15867701 — intervention group
Group type: EXPERIMENTAL
Intervention: High-Cushion Kodel Heel Protector (bunny boot)
Number of subjects: 240
Study 15867701 — intervention group
Group type: EXPERIMENTAL
Intervention: Egg Crate Heel Lift Positioner (egg crate)
Number of subjects: 240
Study 15867701 — intervention group
Group type: EXPERIMENTAL
Intervention: EHOB Foot Waffle Air Cushion (foot waffle)
Number of subjects: 240
Study 15867701 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 240
Study 12185402 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydrocortisone 20 mg administered twice daily for 7 days
Number of subjects: 14
Study 12185402 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 14
Study 12185402 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydrocortisone
Number of subjects: 14
Study 12185402 — intervention group
Group type: EXPERIMENTAL
Intervention: TRH administration after L-tryptophan infusion
Number of subjects: 14
Study 9698728 — intervention group
Group type: EXPERIMENTAL
Intervention: One layer flap (myocutaneous, MC)
Number of subjects: 68
Study 9698728 — intervention group
Group type: COMPARATOR
Intervention: Two layers' dieresis (interfascial, IF)
Number of subjects: 68
Study 8527275 — intervention group
Group type: EXPERIMENTAL
Intervention: Rifampicin 600 mg p.o. daily for 2 weeks
Number of subjects: 9
Study 8527275 — intervention group
Group type: COMPARATOR
Intervention: Quinine alone (no pretreatment)
Number of subjects: 9
Study 8527275 — intervention group
Group type: EXPERIMENTAL
Intervention: Isoniazid 300 mg p.o. daily for 1 week
Number of subjects: 9
Study 2121848 — intervention group
Group type: EXPERIMENTAL
Intervention: Prolonged praziquantel courses (initial dose of 40 mg/Kg, followed by 6-monthly full dose)
Number of subjects: 6
Study 2121848 — intervention group
Group type: EXPERIMENTAL
Intervention: Prolonged praziquantel courses (initial dose of 40 mg/Kg, followed by 3-monthly half doses)
Number of subjects: 6
Study 2121848 — intervention group
Group type: EXPERIMENTAL
Intervention: Prolonged praziquantel courses (initial dose of 40 mg/Kg, followed by monthly half doses)
Number of subjects: 6
Study 2121848 — intervention group
Group type: COMPARATOR
Intervention: Oral vitamin B complex (placebo)
Number of subjects: 6
Study 4577030 — intervention group
Group type: EXPERIMENTAL
Intervention: Uriglox chemical test
Number of subjects: 351
Study 30942613 — intervention group
Group type: EXPERIMENTAL
Intervention: 2 Hz TEAS (n=31)
Number of subjects: 121
Study 30942613 — intervention group
Group type: COMPARATOR
Intervention: Mock stimulation (n=29)
Number of subjects: 121
Study 30942613 — intervention group
Group type: COMPARATOR
Intervention: Control group (lifestyle advice only, n=30)
Number of subjects: 121
Study 27207372 — intervention group
Group type: EXPERIMENTAL
Intervention: PAX good behavior game (PAX GBG)
Number of subjects: 27
Study 27207372 — intervention group
Group type: EXPERIMENTAL
Intervention: Integration of PAX GBG and PATHS
Number of subjects: 27
Study 27207372 — intervention group
Group type: COMPARATOR
Intervention: Control condition
Number of subjects: 27
Study 25598168 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise plus Restwise
Number of subjects: 50
Study 25598168 — intervention group
Group type: COMPARATOR
Intervention: Exercise only
Number of subjects: 50
Study 23570248 — intervention group
Group type: EXPERIMENTAL
Intervention: Clarithromycin (7.5 mg/kg/dose every 12 hours)
Number of subjects: 38
Study 23570248 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 38
Study 21993028 — intervention group
Group type: EXPERIMENTAL
Intervention: 2 depth jumps from a height of 33 cm
Number of subjects: 14
Study 21993028 — intervention group
Group type: EXPERIMENTAL
Intervention: 4 depth jumps from a height of 33 cm
Number of subjects: 14
Study 21993028 — intervention group
Group type: EXPERIMENTAL
Intervention: 6 depth jumps from a height of 33 cm
Number of subjects: 14
Study 21993028 — intervention group
Group type: COMPARATOR
Intervention: Control condition (no depth jumps)
Number of subjects: 14
Study 19362003 — intervention group
Group type: EXPERIMENTAL
Intervention: Hyaluronan (Ostenil)
Number of subjects: 35
Study 19362003 — intervention group
Group type: COMPARATOR
Intervention: Triamcinolone (Volon A10)
Number of subjects: 35
Study 16928473 — intervention group
Group type: EXPERIMENTAL
Intervention: Wines fined with egg white, isinglass, or non-grape-derived tannins
Number of subjects: 0
Study 16928473 — intervention group
Group type: EXPERIMENTAL
Intervention: Milk protein-fined wine
Number of subjects: 0
Study 16928473 — intervention group
Group type: COMPARATOR
Intervention: Control (unfined wine)
Number of subjects: 0
Study 15201240 — intervention group
Group type: EXPERIMENTAL
Intervention: Troponin T testing
Number of subjects: 213
Study 15201240 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous ST segment monitoring
Number of subjects: 213
Study 15201240 — intervention group
Group type: EXPERIMENTAL
Intervention: Composite end point (cardiac death and acute myocardial infarction)
Number of subjects: 213
Study 15201240 — intervention group
Group type: EXPERIMENTAL
Intervention: Age >= 65 years, diabetes, previous myocardial infarction, congestive heart failure, use of beta blockers or diuretics at admission, 12 lead ECG ST segment depression at admission, troponin T concentration >= 0.10 microg/l, and >= 1 ST vector magnitude episodes
Number of subjects: 213
Study 15201240 — intervention group
Group type: EXPERIMENTAL
Intervention: Age >= 65 years, previous myocardial infarction, and troponin T concentration >= 0.10 microg/l
Number of subjects: 213
Study 10675582 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral methylprednisolone
Number of subjects: 80
Study 10675582 — intervention group
Group type: COMPARATOR
Intervention: Intravenous methylprednisolone
Number of subjects: 80
Study 10675582 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 80
Study 9350559 — intervention group
Group type: EXPERIMENTAL
Intervention: Resorbable barrier (Resolut Regenerative Material)
Number of subjects: 12
Study 9350559 — intervention group
Group type: COMPARATOR
Intervention: Non-resorbable barrier (Gore-Tex Periodontal Material)
Number of subjects: 12
Study 8457776 — intervention group
Group type: EXPERIMENTAL
Intervention: GM-CSF after AuBMT
Number of subjects: 0
Study 8457776 — intervention group
Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 0
Study 2878175 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous subcutaneous insulin infusion
Number of subjects: 36
Study 2878175 — intervention group
Group type: COMPARATOR
Intervention: Conventional insulin treatment
Number of subjects: 36
Study 2878175 — intervention group
Group type: EXPERIMENTAL
Intervention: Insulin infusion
Number of subjects: 36
Study 31478164 — intervention group
Group type: EXPERIMENTAL
Intervention: Lifestyle intervention
Number of subjects: 100
Study 29356462 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous drip of 99 Tc-MDP
Number of subjects: 120
Study 29356462 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination treatment of intravenous drip of 99 Tc-MDP and oral meloxicam tablets
Number of subjects: 120
Study 29356462 — intervention group
Group type: COMPARATOR
Intervention: Oral meloxicam tablets
Number of subjects: 120
Study 27388600 — intervention group
Group type: EXPERIMENTAL
Intervention: Brief, multi-component gatekeeper intervention
Number of subjects: 106
Study 27388600 — intervention group
Group type: COMPARATOR
Intervention: Attention control
Number of subjects: 106
Study 25294786 — intervention group
Group type: EXPERIMENTAL
Intervention: Apixaban
Number of subjects: 18201
Study 25294786 — intervention group
Group type: COMPARATOR
Intervention: Warfarin
Number of subjects: 18201
Study 22758783 — intervention group
Group type: EXPERIMENTAL
Intervention: Electrical cardioversion (ECV)
Number of subjects: 521
Study 22758783 — intervention group
Group type: EXPERIMENTAL
Intervention: Previous ECV
Number of subjects: 521
Study 22758783 — intervention group
Group type: EXPERIMENTAL
Intervention: Left atrium enlargement
Number of subjects: 521
Study 22758783 — intervention group
Group type: EXPERIMENTAL
Intervention: AF duration >6 months at time of procedure
Number of subjects: 521
Study 19804441 — intervention group
Group type: EXPERIMENTAL
Intervention: Low dose fluticasone 100 microg/day with intranasal placebo
Number of subjects: 25
Study 19804441 — intervention group
Group type: EXPERIMENTAL
Intervention: High dose fluticasone 500 microg/day with intranasal placebo
Number of subjects: 25
Study 19804441 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined fluticasone 100 microg/day with intranasal fluticasone 200 microg/day
Number of subjects: 25
Study 19804441 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined treatment
Number of subjects: 25
Study 19804441 — intervention group
Group type: EXPERIMENTAL
Intervention: All treatments
Number of subjects: 25
Study 19804441 — intervention group
Group type: COMPARATOR
Intervention: High dose fluticasone vs Low dose fluticasone
Number of subjects: 25
Study 19804441 — intervention group
Group type: COMPARATOR
Intervention: Combined vs Low dose fluticasone
Number of subjects: 25
Study 18559634 — intervention group
Group type: EXPERIMENTAL
Intervention: Facilitatory insole
Number of subjects: 40
Study 18559634 — intervention group
Group type: COMPARATOR
Intervention: Conventional insole
Number of subjects: 40
Study 15847950 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluoxetine 20 mg/day
Number of subjects: 23
Study 15847950 — intervention group
Group type: COMPARATOR
Intervention: Paroxetine 20 mg/day
Number of subjects: 23
Study 12416538 — intervention group
Group type: EXPERIMENTAL
Intervention: Upper removable appliance (URA)
Number of subjects: 23
Study 12416538 — intervention group
Group type: COMPARATOR
Intervention: Jones Jig
Number of subjects: 23